Rapid Spread and Control of Multidrug-Resistant Gram-Negative Bacteria in COVID-19 Patient Care Units
Ashka Patel, Michele Emerick, Marie K Cabunoc, Michelle H Williams, Michael Anne Preas, Gregory Schrank, Ronald Rabinowitz, Paul Luethy, J Kristie Johnson, Surbhi Leekha, Ashka Patel, Michele Emerick, Marie K Cabunoc, Michelle H Williams, Michael Anne Preas, Gregory Schrank, Ronald Rabinowitz, Paul Luethy, J Kristie Johnson, Surbhi Leekha
Abstract
We describe rapid spread of multidrug-resistant gram-negative bacteria among patients in dedicated coronavirus disease care units in a hospital in Maryland, USA, during May-June 2020. Critical illness, high antibiotic use, double occupancy of single rooms, and modified infection prevention practices were key contributing factors. Surveillance culturing aided in outbreak recognition and control.
Keywords: COVID-19; MDR; Maryland; SARS-CoV-2; United States; antimicrobial resistance; bacteria; bacterial infections; coronavirus disease; gram-negative; multidrug resistant; outbreak; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
Figures
References
- Rawson TM, Moore LSP, Castro-Sanchez E, Charani E, Davies F, Satta G, et al. COVID-19 and the potential long-term impact on antimicrobial resistance. J Antimicrob Chemother. 2020;75:1681–4. 10.1093/jac/dkaa194
- Nori P, Cowman K, Chen V, Bartash R, Szymczak W, Madaline T, et al. Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge. Infect Control Hosp Epidemiol. 2021;42:84–8. 10.1017/ice.2020.368
- Centers for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19). 2020. [cited 2020 Aug 20].
- Hill JT, Tran K-DT, Barton KL, Labreche MJ, Sharp SE. Evaluation of the nanosphere Verigene BC-GN assay for direct identification of gram-negative bacilli and antibiotic resistance markers from positive blood cultures and potential impact for more-rapid antibiotic interventions. J Clin Microbiol. 2014;52:3805–7. 10.1128/JCM.01537-14
- Donà D, Di Chiara C, Sharland M. Multi-drug-resistant infections in the COVID-19 era: a framework for considering the potential impact. J Hosp Infect. 2020;106:198–9. 10.1016/j.jhin.2020.05.020
- Kaier K, Mutters NT, Frank U. Bed occupancy rates and hospital-acquired infections—should beds be kept empty? Clin Microbiol Infect. 2012;18:941–5. 10.1111/j.1469-0691.2012.03956.x
- Getahun H, Smith I, Trivedi K, Paulin S, Balkhy HH. Tackling antimicrobial resistance in the COVID-19 pandemic. Bull World Health Organ. 2020;98:442–442A. 10.2471/BLT.20.268573
- Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, et al. Bacterial and fungal co-infection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;71:2459–68.
- Vincent J-L, Sakr Y, Singer M, Martin-Loeches I, Machado FR, Marshall JC, et al.; EPIC III Investigators. Prevalence and outcomes of infection among patients in intensive care units in 2017. JAMA. 2020;323:1478–87. 10.1001/jama.2020.2717
- Prestel C, Anderson E, Forsberg K, Lyman M, de Perio MA, Kuhar D, et al. Candida auris outbreak in a COVID-19 specialty care unit—Florida, July–August 2020. MMWR Morb Mortal Wkly Rep. 2021;70:56–7. 10.15585/mmwr.mm7002e3
Source: PubMed